Advanced treatment
TIL (tumour-infiltrating lymphocyte therapy)
Cell therapy that expands lymphocytes already present inside the patient's tumour, then returns them after preparatory treatment.

Not a diagnosis and not final medical advice. Must be reviewed by a doctor.
What is it?
In TIL, the patient's tumor tissue is used to obtain lymphocyte cells that recognize the tumor.
The cells are multiplied in the laboratory, then given back after preparatory therapy which is lymphodeplex.
This approach has been primarily studied in certain solid tumors, including melanoma and some cervical and lung cancers, and is still in the clinical research phase in many indications.
Lymphocytes taken from tumor tissue are multiplied in the laboratory and activated, then returned to the patient to attack tumor cells.
How it works
Lymphocytes taken from tumor tissue are multiplied in the laboratory and activated, then returned to the patient to attack tumor cells.
Position in the treatment pathway: Generally only through clinical trials or special programs, usually after standard therapy no longer produces results.

Which cancers is it usually discussed for?

Lung Cancer
Lung cancer is divided into non-small-cell and small-cell groups, and molecular markers strongly shape which treatment options are discussed.
Open cancer page
Lymphoma
Lymphoma is a malignancy of the lymphatic system with many subtypes, and accurate pathological classification determines the direction of treatment.
Open cancer page
Usually considered
- Tumor tissue that can be accessed to obtain cells.
- Organ conditions that allow preparatory therapy and monitoring.
- Compliance with ongoing study criteria.
Usually not a candidate
- There is not sufficient tumor tissue to obtain cells.
- A medical condition that makes the procedure unacceptable.
- There are no programs or studies available.
What is the process like?
Preparation 1
Removal of tumor tissue.
Preparation 2
Evaluation of organs and infection.
Preparation 3
Preparatory therapy planning.
Monitoring
Close monitoring after infusion.
All preparation
- Removal of tumor tissue.
- Evaluation of organs and infection.
- Preparatory therapy planning.
All monitoring
- Close monitoring after infusion.
- Monitoring infection and blood cell recovery.
- Evaluate response.
Risks and points to watch
Side-effect notes, not a complete list
- Immune system related reactions may occur.
- Infection and decreased blood cells during the recovery period.
What needs to be checked?

Tumour tissue biopsy
Collection of tumour tissue to confirm the diagnosis and provide material for further testing.
View test
PET-CT
Combined imaging that shows metabolic activity and anatomical location.
View test
Blood laboratory tests
Routine blood tests to assess general condition, organ function, and selected markers.
View test
Cost and access
Cost figures depend heavily on location, facility and payer. We do not show estimated figures on this page; what can be prepared first are the questions.
Providers and clinical trials
Access status not yet verified
NO DATA
No studies in the latest registry data mention this treatment category in their description.
Questions for the doctor
- Is there a TIL clinical trial that is appropriate for my condition?
- What is the tissue collection process and how long does it take to prepare?
- How is monitoring after infusion carried out?
Sources
- NCI Dictionary of Cancer Terms(lembaga)
Is TIL (tumour-infiltrating lymphocyte therapy) relevant for my case?
Ask for an initial review. We will explain which documents and markers need to be completed before discussion with a doctor.
Upload reports
Photos or PDFs of pathology, biomarkers, imaging and treatment history.
Case structured
Documents are turned into a structured case summary.
Navigator review
A human navigator checks completeness before anything is shared.
Provider review
With your consent, the case is discussed with providers for assessment and a written quote.
Is TIL (tumour-infiltrating lymphocyte therapy) relevant for my case?
Ask for an initial review. We will explain which documents and markers need to be completed before discussion with a doctor.
After submission, a human navigator reviews your request and contacts you through your chosen channel. The WhatsApp message already includes this page context, so you do not need to explain from the beginning.
Clinical data is not requested in the form and is not sent to analytics. Do not send medical reports through WhatsApp or email; use the secure upload page. We do not promise eligibility or any treatment outcome.
You just read about TIL (tumour-infiltrating lymphocyte therapy). Next:
Next steps
These suggestions come from links between entries in TanyaKanker's database, not from a medical judgement. Each suggestion includes why it appears.
To check
- Tumour tissue biopsy
Diagnostic test
Reason: Memerlukan pemeriksaan
- Blood laboratory tests
Diagnostic test
Reason: Memerlukan pemeriksaan
- PET-CT
Diagnostic test
Reason: Memerlukan pemeriksaan
- Check medical report completeness
Tool
Reason: Prepare documents that still need confirmation
- Prepare questions for your doctor
Tool
Reason: Bring clear questions to the next conversation
What you can do
- Upload medical reports
Build a case summary in twelve steps
Reason: Often the most useful next step after reading this page
- Request a second opinion
Review of the treatment plan
Reason: Relevant when a treatment plan is being considered
- Consult a navigator
A request is recorded with this page context
Reason: For asking the next step directly
Recently updated
- Leukemia
Cancer page
Date: Data revision 2026-09-10
- Brain Cancer
Cancer page
Date: Data revision 2026-09-10
- Pancreatic Cancer
Cancer page
Date: Data revision 2026-09-10
- Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
NCT03191149 - Phase 2
Date: Registry update in the last 30 days (2026-10-15)
Want to follow changes on this topic? Save the page or follow the topic so it is easy to find again. View saved items.
Prepare for your next consultation
Use the free six-question tool to prepare questions for your doctor.

